Detalhe da pesquisa
1.
Extended Safety and Tolerability of Darolutamide for Nonmetastatic Castration-Resistant Prostate Cancer and Adverse Event Time Course in ARAMIS.
Oncologist
; 2024 Feb 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-38394384
2.
Biochemically recurrent prostate cancer in the era of EMBARK and PSMA PET imaging: everything has changed, except the patients.
Curr Opin Oncol
; 36(3): 164-168, 2024 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38573205
3.
Avelumab Maintenance Therapy for Advanced or Metastatic Urothelial Carcinoma.
N Engl J Med
; 383(13): 1218-1230, 2020 09 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-32945632
4.
Plain language summary of results from the JAVELIN Bladder 100 study: avelumab maintenance treatment for advanced urothelial cancer.
Future Oncol
; 18(19): 2361-2371, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35416053
5.
American Cancer Society prostate cancer survivorship care guidelines.
CA Cancer J Clin
; 64(4): 225-49, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-24916760
6.
Ramucirumab plus docetaxel versus placebo plus docetaxel in patients with locally advanced or metastatic urothelial carcinoma after platinum-based therapy (RANGE): overall survival and updated results of a randomised, double-blind, phase 3 trial.
Lancet Oncol
; 21(1): 105-120, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31753727
7.
Systemic therapy in muscle-invasive and metastatic bladder cancer: current trends and future promises.
Future Oncol
; 12(17): 2049-58, 2016 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-27306417
8.
Life under the CABOSUN: Cabozantinib improves quality-adjusted survival in comparison with sunitinib.
Cancer
; 126(24): 5210-5212, 2020 12 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-33022092
9.
Drug therapies for metastatic castration-resistant prostate cancer.
Future Oncol
; 11(17): 2395-403, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-26274603
10.
Advances in systemic therapies for metastatic castration-resistant prostate cancer.
Future Oncol
; 10(14): 2213-26, 2014 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-25471035
11.
Avelumab First-line Maintenance for Advanced Urothelial Carcinoma: Analysis from JAVELIN Bladder 100 by Duration of First-line Chemotherapy and Interval Before Maintenance.
Eur Urol
; 85(2): 154-163, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-37714742
12.
The role of switch maintenance therapy in urothelial cancers.
Ther Adv Urol
; 15: 17562872221147760, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36891217
13.
Mechanistic Insights on Localized to Metastatic Prostate Cancer Transition and Therapeutic Opportunities.
Res Rep Urol
; 15: 519-529, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-38050587
14.
Emerging treatment options for prostate cancer.
Expert Rev Anticancer Ther
; 23(6): 625-631, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-37101345
15.
A systematic review evaluating the effectiveness of exercise training on physical condition in prostate cancer patients undergoing androgen deprivation therapy.
Transl Androl Urol
; 12(8): 1336-1350, 2023 Aug 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-37680229
16.
Avelumab First-Line Maintenance for Advanced Urothelial Carcinoma: Results From the JAVELIN Bladder 100 Trial After ≥2 Years of Follow-Up.
J Clin Oncol
; 41(19): 3486-3492, 2023 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37071838
17.
Treatment of adult soft tissue sarcoma: old concepts, new insights, and potential for drug discovery.
Cancer Invest
; 30(4): 300-8, 2012 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-22480231
18.
Advances with androgen deprivation therapy for prostate cancer.
Expert Opin Pharmacother
; 23(9): 1015-1033, 2022 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-35108137
19.
Non-urothelial and urothelial variants of bladder cancer.
Cancer Treat Res Commun
; 33: 100661, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36442362
20.
Safety, tolerability and efficacy of agonist anti-CD27 antibody (varlilumab) administered in combination with anti-PD-1 (nivolumab) in advanced solid tumors.
J Immunother Cancer
; 10(8)2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35940825